ADPT EPS Estimates
Adaptive Biotechnologies Corporation
$30.26
+$2.28(+8.15%)
67
Overall
40
Value
90
Tech
71
Quality
Market Cap
$4.90B
Volume
2.83M
52W Range
$12.00 - $30.74
Target Price
$30.50
ADPT EPS estimates: the consensus estimate for Adaptive Biotechnologies Corporation's current fiscal year is -$0.40 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ADPT EPS Estimates
- EPS estimate, current quarter
- $-0.06
- EPS estimate, next quarter
- $-0.09
- EPS estimate, current year
- $-0.40
- EPS estimate, next year
- $-0.19
- EPS growth, 3-year
- +34.69%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.39 |
| 2024 | $-1.08 |
| 2023 | $-1.56 |
| 2022 | $-1.40 |
| 2021 | $-1.48 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADPT | $30.26 | +8.1% | 2.83M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Adaptive Biotechnologies Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW